Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Phase 2 Recruiting
224 enrolled
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Phase 2 Completed
21 enrolled 6 charts
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
48 enrolled 14 charts
A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...
Phase 2 Completed
37 enrolled 10 charts
S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Phase 2 Completed
42 enrolled 8 charts
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
Phase 2 Unknown
Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
Phase 2 Unknown
25 enrolled
Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
Phase 2 Unknown
75 enrolled
Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis
Phase 2 Completed
50 enrolled
Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Unknown
Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer
Phase 2 Unknown
35 enrolled
Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Unknown
39 enrolled
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
Phase 2 Completed
Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer
Phase 2 Unknown
42 enrolled
Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
Phase 2 Completed
Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer
Phase 2 Completed
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
Phase 2 Completed
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Terminated
46 enrolled
Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
Phase 2 Completed
Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer
Phase 2 Unknown
90 enrolled
Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx
Phase 2 Completed
50 enrolled
Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Phase 2 Completed
60 enrolled
Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
47 enrolled
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer
Phase 2 Completed
30 enrolled
Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
Phase 2 Completed
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
45 enrolled
Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 2 Unknown
46 enrolled
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
Phase 2 Completed
Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer
Phase 2 Unknown
35 enrolled
Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
Phase 2 Completed
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
Phase 2 Unknown
Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
Phase 2 Unknown
60 enrolled